Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Phthalate exposure as a risk factor for hypertension


Phthalates are ubiquitous in environment. Hypertension is a major risk factor for cardiovascular diseases. Phthalate exposure is associated with hypertension in multiple studies. This review aims to summarize the scientific literature on associations between phthalate exposure and hypertension and discuss the mechanisms in the relationship. We identified and reviewed original articles published to March 2018, using PubMed and Web of Science to search the terms “phthalate(s),” “phthalic acid,” “blood pressure,” “high blood pressure,” “hypertension,” “prehypertension,” and “cardiovascular disease.” Findings were summarized based on the relevance to the themes, including presentation of main phthalates and their major metabolites as well as associations of phthalate exposure with blood pressure in epidemiological and experimental studies. We identified ten population-based investigations and five toxicological experiments. Epidemiological data underscored a possible correlation between phthalate exposure and hypertension in adults, whereas individual study in children stands on the opposite. Experimental studies mainly targeted the increasing effect of phthalates on blood pressure. This review suggested some underlying mechanisms of phthalate-associated hypertension. Considering the current evidence, phthalate might be risk factors of hypertension. However, the effect of phthalate exposure in early life on blood pressure in later life or adulthood is still unclear. Well-designed longitudinal and molecular mechanism studies are indispensable.

This is a preview of subscription content, log in to check access.


  1. Adrogue HJ, Madias NE (2017) Sodium and potassium in the pathogenesis of hypertension: focus on the brain. Curr Opin Nephrol Hypertens 26:106–113.

  2. Afolayan AJ, Eis A, Alexander M, Michalkiewicz T, Teng RJ, Lakshminrusimha S, Konduri GG (2016) Decreased endothelial nitric oxide synthase expression and function contribute to impaired mitochondrial biogenesis and oxidative stress in fetal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 310:L40–L49.

  3. Ait Bamai Y, Shibata E, Saito I, Araki A, Kanazawa A, Morimoto K, Nakayama K, Tanaka M, Takigawa T, Yoshimura T, Chikara H, Saijo Y, Kishi R (2014) Exposure to house dust phthalates in relation to asthma and allergies in both children and adults. Sci Total Environ 485-486:153–163.

  4. Awasthi AK, Zeng X, Li J (2016) Relationship between e-waste recycling and human health risk in India: a critical review. Environ Sci Pollut Res Int 23:11509–11532.

  5. Bao W, Threefoot SA, Srinivasan SR, Berenson GS (1995) Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens 8:657–665.

  6. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI (2001) Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19:857–861

  7. Bautista LE, Vera LM, Arenas IA, Gamarra G (2005) Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 19:149–154.

  8. Bradley EL, Burden RA, Bentayeb K, Driffield M, Harmer N, Mortimer DN, Speck DR, Ticha J, Castle L (2013) Exposure to phthalic acid, phthalate diesters and phthalate monoesters from foodstuffs: UK total diet study results. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 30:735–742.

  9. Braun JM, Smith KW, Williams PL, Calafat AM, Berry K, Ehrlich S, Hauser R (2012) Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect 120:739–745.

  10. Campioli E, Martinez-Arguelles DB, Papadopoulos V (2014) In utero exposure to the endocrine disruptor di-(2-ethylhexyl) phthalate promotes local adipose and systemic inflammation in adult male offspring. Nutr Diabetes 4:e115.

  11. Cunningham MW Jr, Sasser JM, West CA, Milani CJ, Baylis C, Mitchell KD (2013) Renal nitric oxide synthase and antioxidant preservation in Cyp1a1-Ren-2 transgenic rats with inducible malignant hypertension. Am J Hypertens 26:1242–1249.

  12. Dong R, Zhao S, Zhang H, Chen J, Zhang M, Wang M, Wu M, Li S, Chen B (2017) Sex differences in the association of urinary concentrations of phthalates metabolites with self-reported diabetes and cardiovascular diseases in shanghai adults. Int J Environ Res Public Health 14.

  13. Ejaredar M, Nyanza EC, Ten Eycke K, Dewey D (2015) Phthalate exposure and childrens neurodevelopment: a systematic review. Environ Res 142:51–60.

  14. Falkner B (2015) Recent clinical and translational advances in pediatric hypertension. Hypertension 65:926–931.

  15. Feige JN, Gelman L, Rossi D, Zoete V, Metivier R, Tudor C et al (2007) The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem 282:19152–19166.

  16. Ferguson KK, Cantonwine DE, Rivera-Gonzalez LO, Loch-Caruso R, Mukherjee B, Anzalota Del Toro LV et al (2014) Urinary phthalate metabolite associations with biomarkers of inflammation and oxidative stress across pregnancy in Puerto Rico. Environ Sci Technol 48:7018–7025.

  17. Fierens T, Servaes K, Van Holderbeke M, Geerts L, De Henauw S, Sioen I, Vanermen G (2012) Analysis of phthalates in food products and packaging materials sold on the Belgian market. Food Chem Toxicol 50:2575–2583.

  18. Frederiksen H, Jorgensen N, Andersson AM (2010) Correlations between phthalate metabolites in urine, serum, and seminal plasma from young Danish men determined by isotope dilution liquid chromatography tandem mass spectrometry. J Anal Toxicol 34:400–410

  19. Grassi G (2010) Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 23:1052–1060.

  20. Graves L, Garnett SP, Cowell CT, Baur LA, Ness A, Sattar N, Lawlor DA (2014) Waist-to-height ratio and cardiometabolic risk factors in adolescence: findings from a prospective birth cohort. Pediatr Obes 9:327–338.

  21. Guo Y, Kannan K (2013) A survey of phthalates and parabens in personal care products from the United States and its implications for human exposure. Environ Sci Technol 47:14442–14449.

  22. Hansen JF, Nielsen CH, Brorson MM, Frederiksen H, Hartoft-Nielsen ML, Rasmussen AK, Bendtzen K, Feldt-Rasmussen U (2015) Influence of phthalates on in vitro innate and adaptive immune responses. PLoS One 10:e0131168.

  23. Heacock M, Kelly CB, Asante KA, Birnbaum LS, Bergman AL, Brune MN et al (2016) E-waste and harm to vulnerable populations: a growing global problem. Environ Health Perspect 124:550–555.

  24. Heijnen BF, Van Essen H, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA (2014) Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats. Hypertens Res 37:100–109.

  25. Heudorf U, Mersch-Sundermann V, Angerer J (2007) Phthalates: toxicology and exposure. Int J Hyg Environ Health 210:623–634.

  26. Hubinger JC (2010) A survey of phthalate esters in consumer cosmetic products. J Cosmet Sci 61:457–465

  27. Jaimes R 3rd, Swiercz A, Sherman M, Muselimyan N, Marvar PJ, Posnack NG (2017) Plastics and cardiovascular health: phthalates may disrupt heart rate variability and cardiovascular reactivity. Am J Physiol Heart Circ Physiol 313:H1044–h1053.

  28. James-Todd TM, Huang T, Seely EW, Saxena AR (2016) The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001-2010. Environ Health 15:52.

  29. James-Todd TM, Meeker JD, Huang T, Hauser R, Seely EW, Ferguson KK, Rich-Edwards JW, McElrath TF (2017) Racial and ethnic variations in phthalate metabolite concentration changes across full-term pregnancies. J Expo Sci Environ Epidemiol 27:160–166.

  30. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS, Mitchell GF (2012) Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 308:875–881.

  31. Kagura J, Adair LS, Musa MG, Pettifor JM, Norris SA (2015) Blood pressure tracking in urban black South African children: birth to twenty cohort. BMC Pediatr 15:78.

  32. Karbach S, Wenzel P, Waisman A, Munzel T, Daiber A (2014) eNOS uncoupling in cardiovascular diseases—the role of oxidative stress and inflammation. Curr Pharm Des 20:3579–3594

  33. Kazi TG, Shah F, Shaikh HR, Afridi HI, Shah A, Naeemullah, Arain SS (2014) Exposure of lead to mothers and their new born infants, residents of industrial and domestic areas of Pakistan. Environ Sci Pollut Res Int 21:3021–3030.

  34. Laurenzana EM, Coslo DM, Vigilar MV, Roman AM, Omiecinski CJ (2016) Activation of the constitutive androstane receptor by monophthalates. Chem Res Toxicol 29:1651–1661.

  35. Lee CG (2014) The emerging epidemic of hypertension in Asian children and adolescents. Curr Hypertens Rep 16:495.

  36. Lee KI, Chiang CW, Lin HC, Zhao JF, Li CT, Shyue SK, Lee TS (2015) Maternal exposure to di-(2-ethylhexyl) phthalate exposure deregulates blood pressure, adiposity, cholesterol metabolism and social interaction in mouse offspring. Arch Toxicol 90:1211–1224.

  37. Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, Chen Y, Bian Z, Chen J, Meng J, Xiong Y, He T, Pang Z, Zhang S, Collins R, Peto R, Li L, Chen Z, for the China Kadoorie Biobank Consortium (2016) The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med 176:524–532.

  38. Li Q, Youn JY, Cai H (2015) Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. J Hypertens 33:1128–1136.

  39. Li B, Xu X, Zhu Y, Cao J, Zhang Y, Huo X (2016) Neonatal phthalate ester exposure induced placental MTs, FATP1 and HFABP mRNA expression in two districts of southeast China. Sci Rep 6:21004.

  40. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, AlMazroa MA, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng ATA, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FGR, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD III, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Memish ZA, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Hanafiah KM, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CDH, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA III, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJC, Steenland K, Stöckl H, Stovner LJ, Straif K, Straney L, Thurston GD, Tran JH, van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJL, Ezzati M (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224–2260.

  41. Lind L, Lind PM (2012) Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease? J Intern Med 271:537–553.

  42. Liu WL, Shen CF, Zhang Z, Zhang CB (2009) Distribution of phthalate esters in soil of e-waste recycling sites from Taizhou city in China. Bull Environ Contam Toxicol 82:665–667.

  43. Lytsy P, Lind L, Sundstrom J (2013) Endothelial function and risk of hypertension and blood pressure progression: the prospective investigation of the vasculature in Uppsala seniors. J Hypertens 31:936–939.

  44. Ma TT, Christie P, Luo YM, Teng Y (2013) Phthalate esters contamination in soil and plants on agricultural land near an electronic waste recycling site. Environ Geochem Health 35:465–476.

  45. Mamun AA, Kinarivala MK, O’Callaghan M, Williams G, Najman J, Callaway L (2012) Does hypertensive disorder of pregnancy predict offspring blood pressure at 21 years? Evidence from a birth cohort study. J Hum Hypertens 26:288–294.

  46. Martinez-Arguelles DB, Papadopoulos V (2016) Prenatal phthalate exposure: epigenetic changes leading to lifelong impact on steroid formation. Andrology 4:573–584.

  47. Martinez-Arguelles DB, Guichard T, Culty M, Zirkin BR, Papadopoulos V (2011) In utero exposure to the antiandrogen di-(2-ethylhexyl) phthalate decreases adrenal aldosterone production in the adult rat. Biol Reprod 85:51–61.

  48. Martinez-Arguelles DB, McIntosh M, Rohlicek CV, Culty M, Zirkin BR, Papadopoulos V (2013) Maternal in utero exposure to the endocrine disruptor di-(2-ethylhexyl) phthalate affects the blood pressure of adult male offspring. Toxicol Appl Pharmacol 266:95–100.

  49. Matsumoto M, Hirata-Koizumi M, Ema M (2008) Potential adverse effects of phthalic acid esters on human health: a review of recent studies on reproduction. Regul Toxicol Pharmacol 50:37–49.

  50. Mattace-Raso FU, Verwoert GC, Hofman A, Witteman JC (2010) Inflammation and incident-isolated systolic hypertension in older adults: the Rotterdam study. J Hypertens 28:892–895.

  51. Munoz M, Sanchez A, Pilar Martinez M, Benedito S, Lopez-Oliva ME, Garcia-Sacristan A et al (2015) COX-2 is involved in vascular oxidative stress and endothelial dysfunction of renal interlobar arteries from obese Zucker rats. Free Radic Biol Med 84:77–90.

  52. Munroe PB, Barnes MR, Caulfield MJ (2013) Advances in blood pressure genomics. Circ Res 112:1365–1379.

  53. Nishioka J, Iwahara C, Kawasaki M, Yoshizaki F, Nakayama H, Takamori K, Ogawa H, Iwabuchi K (2012) Di-(2-ethylhexyl) phthalate induces production of inflammatory molecules in human macrophages. Inflamm Res 61:69–78.

  54. Olsen L, Lind L, Lind PM (2012) Associations between circulating levels of bisphenol A and phthalate metabolites and coronary risk in the elderly. Ecotoxicol Environ Saf 80:179–183.

  55. Ostrowska-Nawarycz L, Nawarycz T (2007) Prevalence of excessive body weight and high blood pressure in children and adolescents in the city of Lodz. Kardiol Pol 65:1079–1087 discussion 1088-1079

  56. Pak VM, McCauley LA, Pinto-Martin J (2011) Phthalate exposures and human health concerns: a review and implications for practice. AAOHN J 59:228–233; quiz 234-225.

  57. Park SH, Lim JE, Park H, Jee SH (2016) Body burden of persistent organic pollutants on hypertension: a meta-analysis. Environ Sci Pollut Res Int 23:14284–14293.

  58. Perkins JT, Petriello MC, Newsome BJ, Hennig B (2016) Polychlorinated biphenyls and links to cardiovascular disease. Environ Sci Pollut Res Int 23:2160–2172.

  59. Posnack NG, Swift LM, Kay MW, Lee NH, Sarvazyan N (2012) Phthalate exposure changes the metabolic profile of cardiac muscle cells. Environ Health Perspect 120:1243–1251.

  60. Poulter NR, Prabhakaran D, Caulfield M (2015) Hypertension. Lancet 386:801–812.

  61. Rabinovitch M, Guignabert C, Humbert M, Nicolls MR (2014) Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res 115:165–175.

  62. Rahmani A, Soleimannejad K, Hafezi Ahmadi MR, Asadollahi K, Khalighi Z (2016) Prenatal exposure to phthalic acid induces increased blood pressure, oxidative stress, and markers of endothelial dysfunction in rat offspring. Cardiovasc Toxicol 16:307–315.

  63. Raj M, Krishnakumar R (2013) Hypertension in children and adolescents: epidemiology and pathogenesis. Indian J Pediatr 80(Suppl 1):S71–S76.

  64. Rodriguez-Iturbe B, Franco M, Johnson RJ (2013) Impaired pressure natriuresis is associated with interstitial inflammation in salt-sensitive hypertension. Curr Opin Nephrol Hypertens 22:37–44.

  65. Schettler T (2006) Human exposure to phthalates via consumer products. Int J Androl 29:134–139; discussion 181-135.

  66. Shih MF, Pan KH, Cherng JY (2015) Possible mechanisms of Di(2-ethylhexyl) phthalate-induced MMP-2 and MMP-9 expression in A7r5 rat vascular smooth muscle cells. Int J Mol Sci 16:28800–28811.

  67. Shiue I (2013) Urine phthalate concentrations are higher in people with stroke: United States National Health and Nutrition Examination Surveys (NHANES), 2001-2004. Eur J Neurol 20:728–731.

  68. Shiue I (2014a) Higher urinary heavy metal, arsenic, and phthalate concentrations in people with high blood pressure: US NHANES, 2009-2010. Blood Press 23:363–369.

  69. Shiue I (2014b) Higher urinary heavy metal, phthalate, and arsenic but not parabens concentrations in people with high blood pressure, U.S. NHANES, 2011-2012. Int J Environ Res Public Health 11:5989–5999.

  70. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL, Calafat AM (2004) Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 112:331–338

  71. Singh S, Li SS (2012) Epigenetic effects of environmental chemicals bisphenol A and phthalates. Int J Mol Sci 13:10143–10153.

  72. Singh M, Mensah GA, Bakris G (2010) Pathogenesis and clinical physiology of hypertension. Cardiol Clin 28:545–559.

  73. Sirivarasai J, Wananukul W, Kaojarern S, Chanprasertyothin S, Thongmung N, Ratanachaiwong W et al (2013) Association between inflammatory marker, environmental lead exposure, and glutathione S-transferase gene. Toxicol Lett 221:474963

  74. Solak Y, Afsar B, Vaziri ND, Aslan G, Yalcin CE, Covic A, Kanbay M (2016) Hypertension as an autoimmune and inflammatory disease. Hypertens Res 39:567–573.

  75. Stea F, Bianchi F, Cori L, Sicari R (2014) Cardiovascular effects of arsenic: clinical and epidemiological findings. Environ Sci Pollut Res Int 21:244–251.

  76. Strac IV, Pusic M, Gajski G, Garaj-Vrhovac V (2013) Presence of phthalate esters in intravenous solution evaluated using gas chromatography-mass spectrometry method. J Appl Toxicol 33:214–219.

  77. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH et al (2003) High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 16:429–433

  78. Supornsilchai V, Soder O, Svechnikov K (2007) Stimulation of the pituitary-adrenal axis and of adrenocortical steroidogenesis ex vivo by administration of di-2-ethylhexyl phthalate to prepubertal male rats. J Endocrinol 192:33–39.

  79. Tamosiuniene R, Tian W, Dhillon G, Wang L, Sung YK, Gera L, Patterson AJ, Agrawal R, Rabinovitch M, Ambler K, Long CS, Voelkel NF, Nicolls MR (2011) Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ Res 109:867–879.

  80. Tomat AL, Salazar FJ (2014) Mechanisms involved in developmental programming of hypertension and renal diseases. Gender differences. Horm Mol Biol Clin Investig 18:63–77.

  81. Tran TM, Kannan K (2015) Occurrence of phthalate diesters in particulate and vapor phases in indoor air and implications for human exposure in Albany, New York, USA. Arch Environ Contam Toxicol 68:489–499.

  82. Trasande L, Attina TM (2015) Association of exposure to di-2-ethylhexylphthalate replacements with increased blood pressure in children and adolescents. Hypertension 66:301–308.

  83. Trasande L, Sathyanarayana S, Spanier AJ, Trachtman H, Attina TM, Urbina EM (2013) Urinary phthalates are associated with higher blood pressure in childhood. J Pediatr 163 e741:747–753.

  84. Valvi D, Casas M, Romaguera D, Monfort N, Ventura R, Martinez D, Sunyer J, Vrijheid M (2015) Prenatal phthalate exposure and childhood growth and blood pressure: evidence from the Spanish INMA-Sabadell Birth Cohort Study. Environ Health Perspect 123:1022–1029.

  85. Wei Z, Song L, Wei J, Chen T, Chen J, Lin Y, Xia W, Xu B, Li X, Chen X, Li Y, Xu S (2012) Maternal exposure to di-(2-ethylhexyl)phthalate alters kidney development through the renin-angiotensin system in offspring. Toxicol Lett 212:212–221.

  86. Werner EF, Braun JM, Yolton K, Khoury JC, Lanphear BP (2015) The association between maternal urinary phthalate concentrations and blood pressure in pregnancy: the HOME Study. Environ Health 14:75.

  87. Wise IA, Charchar FJ (2016) Epigenetic modifications in essential hypertension. Int J Mol Sci 17.

  88. Xiao D, Huang X, Yang S, Zhang L (2011) Antenatal nicotine induces heightened oxidative stress and vascular dysfunction in rat offspring. Br J Pharmacol 164:1400–1409.

  89. Xu Y, Agrawal S, Cook TJ, Knipp GT (2008) Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. Placenta 29:962–969.

  90. Xu Y, Cohen Hubal EA, Little JC (2010) Predicting residential exposure to phthalate plasticizer emitted from vinyl flooring: sensitivity, uncertainty, and implications for biomonitoring. Environ Health Perspect 118:253–258.

  91. Zarean M, Keikha M, Poursafa P, Khalighinejad P, Amin M, Kelishadi R (2016) A systematic review on the adverse health effects of di-2-ethylhexyl phthalate. Environ Sci Pollut Res Int 23:24642–24693.

Download references


This work was supported by the Project of International Cooperation and Innovation Platform in Guangdong Universities (2013gjhz0007) and the Education Department of Guangdong Government under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases (2016046).

Author information

Correspondence to Xia Huo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Responsible editor: Philippe Garrigues

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lu, X., Xu, X., Lin, Y. et al. Phthalate exposure as a risk factor for hypertension. Environ Sci Pollut Res 25, 20550–20561 (2018).

Download citation


  • Phthalates
  • Blood pressure
  • Hypertension
  • Cardiovascular disease
  • Risk factor